This is a clone of the Texas Administrative Code (TAC) for educational purposes. It is not the official version and should not be used for legal purposes. Site created Wed, 21 May 2025 21:16:43 GMT

Home > Title 25 > Part 1 > Chapter 1 >Subchapter A > Rule 1.1
TITLE 25 - HEALTH SERVICES
PART 1 - DEPARTMENT OF STATE HEALTH SERVICES
CHAPTER 1 - MISCELLANEOUS PROVISIONS
SUBCHAPTER A - INVESTIGATIONAL TREATMENTS FOR PATIENTS WITH SEVERE CHRONIC DISEASES
SECTION/RULE §1.1 - Purpose and Scope
Chapter Review Date 08/28/2024

(a) The purpose of this subchapter is to establish the requirements for a patient with a severe chronic disease to access and use an investigational drug, biological product, or device, consistent with Texas Health and Safety Code Chapter 490 and the rules in this subchapter.(b) Texas Health and Safety Code Chapter 490 and the rules in this subchapter do not require a manufacturer to make available an investigational drug, biological product, or device to an eligible patient but a manufacturer choosing to do so must not receive compensation.

Source Note: The provisions of this §1.1 adopted to be effective August 19, 2024, 49 TexReg 6215.

View Official Rule